PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy VolunteersMichelle Mellion,Jane Larkindale,Pallavi Lonkar,Jaya Goyal,Ashling Holland, Jeff Foy, Brijesh Garg,Shaoxia Yu, Anthony Frank,Chris Abbott,Niels Svenstrup,Jennifer Cormier, Sarah Vacca, James McArthurNEUROLOGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
